BarrettHChildsMD

Physician

Dr. Childs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5410 Netherland Avenue
Riverdale, NY 10471
Phone+1 917-214-7887

Fax+1 862-404-4303

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1982 - 1985
Rutgers Robert Wood Johnson Medical SchoolClass of 1982, MD

PubMed

11 citations
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian ca...
Alessandro D Santin, Ignace Vergote, Antonio González-Martín, Kathleen Moore, Ana Oaknin
International Journal of Gynecological Cancer. 2023-04-03
1 citations
PI3K inhibitors in haematological malignancies.
Matthew J Matasar, Florian Hiemeyer, Barrett H Childs, Pier Luigi Zinzani
The Lancet. Oncology. 2022-08-01
4 citations
A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma.
Weiping Liu, Lingyan Ping, Yan Xie, Yingli Sun, Tingting Du
Cancer Chemotherapy and Pharmacology. 2022-06-01

Lectures

Outcomes for Patients with Pre-Existing Diabetes or Hypertension Treated with Copanlisib from the CHRONOS- Study in Patients with Relapsed or Refractory Indolent B-Cel...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Long-Term Efficacy and Safety from the Copanlisib CHRONOS- Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018